Using ctDNA to Determine Therapies for Lung Cancer

NCT04966663 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer
Complete Surgical Resection
Circulating Tumor DNA

Interventions

DRUG: Nivolumab
DRUG: Pemetrexed
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Carboplatin
PROCEDURE: ctDNA blood test

Sponsor

University Health Network, Toronto

Collaborators

[object Object]